AI-generated summary
The authors applied daily dorsoventral photobiomodulation therapy to mice with experimental autoimmune encephalomyelitis, a model that resembles multiple sclerosis, and examined spinal cord changes. They report reduced immune cell infiltration, glial reactivity and interneuron hyperexcitability, along with improved sensorimotor deficits. The study was conducted in mice, so its relevance to human multiple sclerosis is uncertain.
- Who or what was studied
- Mice with experimental autoimmune encephalomyelitis (EAE) and healthy mice
- Limits stated in the abstract
- The study was conducted in a mouse model of multiple sclerosis, and the abstract does not state any human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jneuroinflammation.biomedcentral.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Inflammation, Photon. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.